Share

    


Home / Search Results

Search Results

You searched for:

Patients with cancer who face transportation barriers often find themselves at a crossroads: They must either continue to piece together various forms of assistance to try to complete a treatment regimen and protocol or throw in the towel altogether. Instead of reacting to patients’ needs after they fall out of compliance with their specified treatment, we pledged to proactively offer and find transportation …
Dr. Vijay Rao and Dr. Eric Stephen Rubenstein returned from a Global Cardio-Oncology Society meeting g with the realization that they could do much more to protect patients with cancer from potential cardiac toxicity of chemotherapy. The two shared one goal: to prevent the cancer survivor of today from becoming the heart failure patient of tomorrow.
10 accc-cancer.org | Vol. 36, No. 3, 2021 | OI patients with a healthy support system in place or those who receive health behavioral services tend to do better and experience better outcomes. A 2019 article published in BMC Psychiatry found that the incidence of psychological disorders in patients with cancer is very high, somewhere between 30 and 60 percent.1 The most encountered problems …
It is well documented, even beyond Tennessee Oncology's OCM experience, that patients with cancer generally have some type of hospital-related costs during their disease treatment. Understanding the impact of these real-time alerts and data, Tennessee Oncology formed a Care Transformation Team with the focus of addressing admissions in real time, as well as follow-up care for discharges.
Rather than fielding its annual Trending Now in Cancer Care survey while cancer programs were experiencing unprecedented challenges due to the extended public health emergency, ACCC chose to facilitate conversations with its members to capture the lived experiences of the most pertinent issues impacting oncology practice and care delivery.
One important step toward supporting the health of Indigenous Peoples was the opening of the Center for Indigenous Cancer Research (CICR) at Roswell Park Comprehensive Cancer Center in January 2020. Its mission: to reduce the impact of cancer on Indigenous communities regionally, nationally, and internationally.
In 2016, the Association of Community Cancer Centers (ACCC) initiated a three-year multiphase project to develop an Optimal Care Coordination Model (OCCM) for Medicaid patients with lung cancer that would help assess and strengthen care delivery systems by facilitating and expanding access to multidisciplinary coordinated care.
Read about this model that engages oncology stakeholders in advancing biomarker testing and application into practice, increasing access to state-of-the-art genomic testing and clinical trials.
The OCCM was designed to be a usable framework that offers lung cancer programs, regardless of setting, size, and resource level, and the flexibility to conduct continuous assessments of care coordination practices and measure strengths and opportunities in the pursuit of optimal patient outcomes.
Cancer programs of all types across the U.S. face similar challenges in providing quality care for women with ovarian cancer. Multiple stakeholders can contribute to QI solutions with a team approach and clear communication around quality gaps.
To improve the care of these patients, MaineHealth, Maine Cancer Care Network designed a study to explore the use of a 3D lung nodule tool to help providers educate patients during shared decision-making consults.
In 2020 ACCC offered quality improvement programs designed to optimize care for patients with multiple myeloma.
In 2020 ACCC offered quality improvement programs designed to optimize care for patients with acute lymphocytic leukemia.
In 2019 the Association of Community Cancer Centers developed an education program to provide all members of the multidisciplinary care team knowledge and resources to help successfully integrate immunotherapies into the treatment of patients with RCC.
Assuming the ACCC presidency in March of 2020, just as the COVID-19 public health emergency went into effect, was certainly a dramatic way to enter office. That said, I am pleased with how much we have accomplished these last 12 months— despite the nationwide shutdown and ongoing pandemic.
With the enormous pressures of COVID-19, the ever-increasing complexity of oncology care, and the persistent social factors that lead to medical injustice, it is difficult to think about tackling even one more job. Yet, we must, we can, and we do. Today I want to mention four specific areas that all cancer programs need to be watching, thinking about, and preparing for.
This is the story of how a large independent practice in northwest Arkansas has nurtured its research program over several decades and is now able to offer patients access to phase I, II, and III trials close to home and their families.
As the manager of Wellspring, a cancer resource center located just two miles from Valley Health Cancer Center at Winchester Medical Center in Virginia, I understand the importance of providing holistic care that meets the body, mind, and spiritual needs of our patients.
With the rise of immunotherapies, it is critical to ensure patient safety, as the toxicity profiles of immunotherapy agents are vastly different from traditional cytotoxic chemotherapies.
In the current transition to value-based care, avoidable ER utilization represents an opportunity for cost savings, but difficulties remain in determining what visits are and are not avoidable based on coding and billing data alone.